Hypermethylation of ZNF154 promotes malignant potential of ovarian cancer cells by diminishing ZNF154/KAP1-mediated ROMO1 repression
Mingbiao Wei, Yuxia Xu, Ling Deng, Wei Wei, Dongyi Ling, Shanshan Zhen, Ran Zhou, Wenjian Cen, Xu Zhang, Mayan Huang, Jundong Li, Shumei Yan, Qin Li, Ziming Du · 2026
Read Hypermethylation of ZNF154 promotes malignant potential of ovarian cancer cells by diminishing ZNF154/KAP1-mediated ROMO1 repression by Mingbiao Wei, Yuxia Xu, Ling Deng, Wei Wei, Dongyi Ling, Shanshan Zhen, Ran Zhou, Wenjian Cen, Xu Zhang, Mayan Huang, Jundong Li, Shumei Yan, Qin Li, Ziming Du (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13280250.txt.
Description
Mingbiao Wei and co-authors traced in 2026 how a silenced guard gene frees ovarian cancer to grow more fierce. The gene, ZNF154, is shut by heavy methylation, a chemical mute laid by a known enzyme pair. In dishes, a targeted un-muting tool woke the gene, and cancer cells then grew, moved, and invaded less. The gene works with a partner, KAP1, to sit on a second gene, ROMO1, and hold it down.
With ROMO1 held, two spread drivers fell. In patients, heavy muting of the guard gene tracked with its low output and poor outlook. The team names the muting a driver event in this cancer. It may serve as both a forecast mark and a drug target.
Catalog record
| CREATOR | Mingbiao Wei, Yuxia Xu, Ling Deng, Wei Wei, Dongyi Ling, Shanshan Zhen, Ran Zhou, Wenjian Cen, Xu Zhang, Mayan Huang, Jundong Li, Shumei Yan, Qin Li, Ziming Du |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |